About Amorphex Therapeutics Holdings
Amorphex Therapeutics Holdings is a private company based in Andover, Massachusetts, incorporated in 2021 in Delaware. It has reported $265,000 raised in one offering on Form D since January 2023. Its chief executive is Robert Thompson.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 26, 2021 | Jan 20, 2023 | $265,000fully sold | 13 | $20,385 | Equity, DebtRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Amorphex Therapeutics Holdings's Form D filed Jan 20, 2023.
RT
Robert Thompson
Chief Executive Officer and director